1360702-57-3

Upstream product

• 1360624-07-2 N-(3-nitro-2,4-dichloro-benzyl)-2,2-dimethyl-propionamide 
• 1360624-05-0 3-nitro-2,4-dichloro-benzylamine 
• 1360624-03-8 N-(3-nitro-2,4-dichloro-benzyl)-2,2,2-trifluoroacetamide 
• 1360624-01-6 N-(2,4-dichloro-3-isothiocyanato-benzyl)-2,2-dimethyl-propionamide 
• 1218945-53-9 5,6-diamino-2-(2,2-difluoro-ethoxy)-nicotinic acid methyl ester 
• 1360623-99-9 N-(3-amino-2,4-dichloro-benzyl)-2,2-dimethyl-propionamide 
• 1360623-97-7 3-amino-2,4-dichloro-benzylamine 
• 1360623-95-5 3-amino-2,4-dichloro-benzamide 
• 50917-27-6 3-acetamido-2,4-dichlorobenzoic acid 
• 601-88-7 2,6-dichloronitrobenzene 
• 50917-28-7 3-amino-2,4-dichloro-benzoic acid 
• 17700-55-9 N-(2,6-Dichloro-3-methylphenyl)acetamide 

Downstream Products

• 1360702-58-4 N-{2,4-dichloro-3-[6-hydroxycarbonyl-5-(2,2-difluoro-ethoxy)-1H-imidazo[4,5-b]pyridin-2-ylamino]-benzyl}-2,2-dimethyl-propionamide 
• 1360702-58-4 N-{2,4-Dichloro-3-[6-hydroxycarbonyl-5-(2,2-difluoro-ethoxy)-1H-imidazo[4,5-b]pyridin-2-ylamino]benzyl)-2,2-dimethyl-propionamide 

Relevant academic research and scientific papers

NEW COMPOUNDS

This invention relates to compounds of formula I their use as inhibitors of the microsomal prostaglandin E2 synthase-1 (mPGES-1), pharmaceutical compositions containing them, and their use as medicaments for the treatment and/or prevention of i

2-(ARYLAMINO)-3H-IMIDAZO[4,5-B]PYRIDINE-6-CARBOXAMIDE DERIVATIVES AND THEIR USE AS MPGES-1 INHIBITORS

This invention relates to compounds of formula (I) their use as inhibitors of the microsomal prostaglandin E2 synthase-1 (mPGES-1), pharmaceutical compositions containing them, and their use as medicaments for the treatment and/or prevention of